We’re moving the GATK website, docs and forum to a new platform. Read the full story and breakdown of key changes on this blog.
If you happen to see a question you know the answer to, please do chime in and help your fellow community members. We encourage our fourm members to be more involved, jump in and help out your fellow researchers with their questions. GATK forum is a community forum and helping each other with using GATK tools and research is the cornerstone of our success as a genomics research community.We appreciate your help!
Test-drive the GATK tools and Best Practices pipelines on Terra
Check out this blog post to learn how you can get started with GATK and try out the pipelines in preconfigured workspaces (with a user-friendly interface!) without having to install anything.
Mutect2 PoN for RNA-Seq
We're analyzing a batch of RNA samples to identify mutations.
We don't have matched healthy tissue and we are wondering what would be the optimal panel of normals to use.
We are thinking of using RNA-Seq data from healthy subjects. However, the differences in expression (many genes and isoforms will be DE between healthy and patients) will result in numerous regions not having adequate coverage in the PoN.
Using WGS from e.g. 1000G would be a better option? Coverage will definitely be better, since expression is not a factor but we will not be capturing many technical artifacts from the process (reverse transcription, oligo-DT, spliced alignment, etc).
What do you recommend? We know it's an off-label use of the pipeline.